Skip to main content
Clinical Trials/ACTRN12616001508460
ACTRN12616001508460
Completed
Phase 4

What is the extent to which platelet activation in response to infectious agents is reduced following administration of aspirin and ticagrelor in healthy volunteers?

Kathryn Hally0 sites10 target enrollmentNovember 1, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute coronary syndrome
Sponsor
Kathryn Hally
Enrollment
10
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kathryn Hally

Eligibility Criteria

Inclusion Criteria

  • Healthy, aged between 45 and 65

Exclusion Criteria

  • i) known cardiovascular or inflammatory disease,
  • ii) platelet function disorder,
  • iii) a platelet count of less than 100x109/L,
  • iv) taken any anti\-platelet, non\-steroidal anti\-inflammatory drugs or any cardiovascular or immune\-modulating medication within 7 days prior to recruitment,
  • v) acute illness within 6 weeks prior to recruitment,
  • vi) pregnancy,
  • vii) diabetes mellitus,
  • viii) inability to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials